| Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study J Zhang, H Chen, Y Ma, Y Xiao, N Niu, W Lin, X Wang, Z Liang, F Zhang, ... European journal of nuclear medicine and molecular imaging 41, 1624-1634, 2014 | 253 | 2014 |
| Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using 177Lu-FAP-2286: first-in-humans results RP Baum, C Schuchardt, A Singh, M Chantadisai, FC Robiller, J Zhang, ... Journal of Nuclear Medicine 63 (3), 415-423, 2022 | 155 | 2022 |
| Peptide receptor radionuclide therapy in grade 3 neuroendocrine neoplasms: safety and survival analysis in 69 patients J Zhang, HR Kulkarni, A Singh, K Niepsch, D Müller, RP Baum Journal of Nuclear Medicine 60 (3), 377-385, 2019 | 116 | 2019 |
| First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using 68Ga-IRDye800CW-BBN D Li, J Zhang, C Chi, X Xiao, J Wang, L Lang, I Ali, G Niu, L Zhang, J Tian, ... Theranostics 8 (9), 2508, 2018 | 105 | 2018 |
| Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH … H Ahmadzadehfar, K Rahbar, RP Baum, R Seifert, K Kessel, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 113-122, 2021 | 92 | 2021 |
| 68Ga DOTATATE PET/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia J Zhang, Z Zhu, D Zhong, Y Dang, H Xing, Y Du, H Jing, Z Qiao, X Xing, ... Clinical nuclear medicine 40 (8), 642-646, 2015 | 89 | 2015 |
| Clinical translation of a dual integrin αvβ3–and gastrin-releasing peptide receptor–targeting PET radiotracer, 68Ga-BBN-RGD J Zhang, G Niu, L Lang, F Li, X Fan, X Yan, S Yao, W Yan, L Huo, L Chen, ... Journal of Nuclear Medicine 58 (2), 228-234, 2017 | 83 | 2017 |
| PET using a GRPR antagonist 68Ga-RM26 in healthy volunteers and prostate cancer patients J Zhang, G Niu, X Fan, L Lang, G Hou, L Chen, H Wu, Z Zhu, F Li, X Chen Journal of nuclear medicine 59 (6), 922-928, 2018 | 80 | 2018 |
| Safety, pharmacokinetics, and dosimetry of a long-acting radiolabeled somatostatin analog 177Lu-DOTA-EB-TATE in patients with advanced metastatic neuroendocrine tumors J Zhang, H Wang, O Jacobson, Y Cheng, G Niu, F Li, C Bai, Z Zhu, ... Journal of Nuclear Medicine 59 (11), 1699-1705, 2018 | 77 | 2018 |
| Prostate-specific membrane antigen radioligand therapy using 177Lu-PSMA I&T and 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of … C Schuchardt, J Zhang, HR Kulkarni, X Chen, D Müller, RP Baum Journal of Nuclear Medicine 63 (8), 1199-1207, 2022 | 76 | 2022 |
| 68Ga-NOTA-PRGD2 PET/CT for integrin imaging in patients with lung cancer K Zheng, N Liang, J Zhang, L Lang, W Zhang, S Li, J Zhao, G Niu, F Li, ... Journal of Nuclear Medicine 56 (12), 1823-1827, 2015 | 71 | 2015 |
| 68Ga-BBN-RGD PET/CT for GRPR and integrin αvβ3 imaging in patients with breast cancer J Zhang, F Mao, G Niu, L Peng, L Lang, F Li, H Ying, H Wu, B Pan, Z Zhu, ... Theranostics 8 (4), 1121, 2018 | 67 | 2018 |
| Prognostic value of 18F-FDG PET/CT in a large cohort of patients with advanced metastatic neuroendocrine neoplasms treated with peptide receptor radionuclide therapy J Zhang, Q Liu, A Singh, C Schuchardt, HR Kulkarni, RP Baum Journal of Nuclear Medicine 61 (11), 1560-1569, 2020 | 60 | 2020 |
| Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen HR Kulkarni, A Singh, T Langbein, C Schuchardt, D Mueller, J Zhang, ... The British journal of radiology 91 (1091), 20180308, 2018 | 57 | 2018 |
| Clinical translation of an albumin-binding PET radiotracer 68Ga-NEB J Zhang, L Lang, Z Zhu, F Li, G Niu, X Chen Journal of Nuclear Medicine 56 (10), 1609-1614, 2015 | 57 | 2015 |
| Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan H Jing, F Li, H Zhuang, Z Wang, J Tian, X Xing, J Jin, D Zhong, J Zhang European journal of radiology 82 (11), 2028-2034, 2013 | 56 | 2013 |
| First-in-humans study of the SSTR antagonist 177Lu-DOTA-LM3 for peptide receptor radionuclide therapy in patients with metastatic neuroendocrine neoplasms: dosimetry, safety … RP Baum, J Zhang, C Schuchardt, D Müller, H Mäcke Journal of Nuclear Medicine 62 (11), 1571-1581, 2021 | 55 | 2021 |
| 68Ga-NOTA-RM26 PET/CT in the evaluation of breast cancer: a pilot prospective study J Zang, F Mao, H Wang, J Zhang, Q Liu, L Peng, F Li, L Lang, X Chen, ... Clinical nuclear medicine 43 (9), 663-669, 2018 | 50 | 2018 |
| 68Ga-NOTA-Aca-BBN (7–14) PET/CT in healthy volunteers and glioma patients J Zhang, D Li, L Lang, Z Zhu, L Wang, P Wu, G Niu, F Li, X Chen Journal of Nuclear Medicine 57 (1), 9-14, 2016 | 50 | 2016 |
| 177Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer FE Von Eyben, A Singh, J Zhang, K Nipsch, D Meyrick, N Lenzo, ... Oncotarget 10 (25), 2451, 2019 | 40 | 2019 |
Xiaoyuan (Shawn) ChenNational University of SingaporeE-mail megerősítve itt: nus.edu.sg
